Hadasit | Hadassah International

Science fiction? Male and Female Stem Cells Derived from the Same Person with the Same Genetic Code

The following article was originally published in the Hadassah International 2022 Year In Review. To access the complete Hadassah International 2022 Year in Review – click here: Cure. Innovation. Humanity. “For…

Cancer Immunotherapy

Hadassah and MyBiotics Join Forces to Improve Cancer Immunotherapy

Hadasit

First-Ever International Lifetime Achievement Award Goes to Hadassah Psychiatrist

...More than a Hospital

First in Israel: Hadasit Launches Medical Startup Accelerator with IBM

ALS Research

Hadassah and Kadimastem Co-Design Embryonic Stem Cell Protocol for ALS Clinical Trial

Graft vs Host disease

Hadasit and Cellect Team Up for Stem Cell Innovation

Research

Granalix BioTechnologies Introduces Food Additive to Protect Against Neurodegenerative Disease

Drugs and Antibiotics

Collaboration Announced to Develop Hadassah Drug to Treat “Untreatable” NASH Liver Disease

Research

HMO and Hebrew U Students Invent Device to Save Terror Victims

Research

BioDesign Hadassah-Hebrew University Team Invents Solution to Surgical Problem

Cardiology Research

Hadassah-Developed Imaging Agent to Begin Clinical Trials with Multi-million Euro Grant

Liver Disease

Hadassah Drug to Fight Fatty Liver Disease Progressing Well in US Clinical Trials

Liver Research

FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease

Cardiology Research

Hadasit Sets Up Incubator Company to Develop Stent Locator

Liver Research

Hadassah Researchers Identify Connection Between Natural Killer Cell and Cirrhosis

Cancer Research

New Test Developed at Hadassah Predicts Presence of Harmful BRCA Mutation Which Can Trigger Breast Cancer

Cardiology

Hadasit Sets Up Incubator Company to Develop Stent Locator

Bone-marrow (transplantation)

Enlivex Successfully Completes First Trial for Treatment of Graft-Versus-Host Disease (GVHD)

Hematology

Hadassah Researchers Develop Animal-Component Free, Human Embryonic Stem Cell Lines, Suitable for Human Transplantation

Hadasit

Hadassah International

Science fiction? Male and Female Stem Cells Derived from the Same Person with the Same Genetic Code

Science fiction? Male and Female Stem Cells Derived from the Same Person with the Same Genetic Code

Hadassah and MyBiotics Join Forces to Improve Cancer Immunotherapy

First-Ever International Lifetime Achievement Award Goes to Hadassah Psychiatrist

First in Israel: Hadasit Launches Medical Startup Accelerator with IBM

Hadassah and Kadimastem Co-Design Embryonic Stem Cell Protocol for ALS Clinical Trial

Hadasit and Cellect Team Up for Stem Cell Innovation

Granalix BioTechnologies Introduces Food Additive to Protect Against Neurodegenerative Disease

Collaboration Announced to Develop Hadassah Drug to Treat “Untreatable” NASH Liver Disease

HMO and Hebrew U Students Invent Device to Save Terror Victims

BioDesign Hadassah-Hebrew University Team Invents Solution to Surgical Problem

Hadassah-Developed Imaging Agent to Begin Clinical Trials with Multi-million Euro Grant

Hadassah Drug to Fight Fatty Liver Disease Progressing Well in US Clinical Trials

FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease

Hadasit Sets Up Incubator Company to Develop Stent Locator

Hadassah Researchers Identify Connection Between Natural Killer Cell and Cirrhosis

New Test Developed at Hadassah Predicts Presence of Harmful BRCA Mutation Which Can Trigger Breast Cancer

Hadasit Sets Up Incubator Company to Develop Stent Locator

Enlivex Successfully Completes First Trial for Treatment of Graft-Versus-Host Disease (GVHD)

Hadassah Researchers Develop Animal-Component Free, Human Embryonic Stem Cell Lines, Suitable for Human Transplantation

Thrombotech Receives Regulatory Approval for Stroke Medicine Trials in the US